Adverse events | N = 36 |
Patients presenting at least one AE, n % 95% CI (exact) | 36 (100%) (90.3%; 100.0%) |
The total number of AEs reported in the study | 290 |
Days between the start of the trial and adverse events |
|
Mean (SD) | 30 (20.8) |
Median (IQR) | 28 (11.7-46.3) |
Min, Max | 0; 103 |